EDAP Quote, Financials, Valuation and Earnings

Biodexa Pharmaceuticals PLC has a net margin of -48.85% compared to Edap TMS SA's net margin of --. Edap TMS SA's return on equity of -42.5% beat Biodexa Pharmaceuticals PLC's return on equity of -160.77%.

Edap TMS SA has a consensus price target of $10.67, signalling upside risk potential of 365.79%. On the other hand Biodexa Pharmaceuticals PLC has an analysts' consensus of $17.97 which suggests that it could grow by 753.38%. Given that Biodexa Pharmaceuticals PLC has higher upside potential than Edap TMS SA, analysts believe Biodexa Pharmaceuticals PLC is more attractive than Edap TMS SA.

Edap TMS SA has a beta of 0.372, which suggesting that the stock is 62.782% less volatile than S&P 500. In comparison Biodexa Pharmaceuticals PLC has a beta of 1.489, suggesting its more volatile than the S&P 500 by 48.943%.

Edap TMS SA has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Biodexa Pharmaceuticals PLC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Edap TMS SA pays -- of its earnings as a dividend. Biodexa Pharmaceuticals PLC pays out -- of its earnings as a dividend.

Edap TMS SA quarterly revenues are $14.4M, which are larger than Biodexa Pharmaceuticals PLC quarterly revenues of --. Edap TMS SA's net income of -$7M is higher than Biodexa Pharmaceuticals PLC's net income of --. Notably, Edap TMS SA's price-to-earnings ratio is -- while Biodexa Pharmaceuticals PLC's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Edap TMS SA is 1.24x versus 1.91x for Biodexa Pharmaceuticals PLC. Usually stocks with elevated PS ratios are considered overvalued.

Cellectis SA has a net margin of -48.85% compared to Edap TMS SA's net margin of 46.57%. Edap TMS SA's return on equity of -42.5% beat Cellectis SA's return on equity of -31.46%.

Edap TMS SA has a consensus price target of $10.67, signalling upside risk potential of 365.79%. On the other hand Cellectis SA has an analysts' consensus of $5.80 which suggests that it could grow by 373.47%. Given that Cellectis SA has higher upside potential than Edap TMS SA, analysts believe Cellectis SA is more attractive than Edap TMS SA.

Edap TMS SA has a beta of 0.372, which suggesting that the stock is 62.782% less volatile than S&P 500. In comparison Cellectis SA has a beta of 3.275, suggesting its more volatile than the S&P 500 by 227.454%.

Edap TMS SA has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Cellectis SA offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Edap TMS SA pays -- of its earnings as a dividend. Cellectis SA pays out -- of its earnings as a dividend.

Edap TMS SA quarterly revenues are $14.4M, which are larger than Cellectis SA quarterly revenues of $12.7M. Edap TMS SA's net income of -$7M is lower than Cellectis SA's net income of $5.9M. Notably, Edap TMS SA's price-to-earnings ratio is -- while Cellectis SA's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Edap TMS SA is 1.24x versus 2.90x for Cellectis SA. Usually stocks with elevated PS ratios are considered overvalued.

DBV Technologies SA has a net margin of -48.85% compared to Edap TMS SA's net margin of --. Edap TMS SA's return on equity of -42.5% beat DBV Technologies SA's return on equity of --.

Edap TMS SA has a consensus price target of $10.67, signalling upside risk potential of 365.79%. On the other hand DBV Technologies SA has an analysts' consensus of $21.81 which suggests that it could grow by 366.09%. Given that DBV Technologies SA has higher upside potential than Edap TMS SA, analysts believe DBV Technologies SA is more attractive than Edap TMS SA.

Edap TMS SA has a beta of 0.372, which suggesting that the stock is 62.782% less volatile than S&P 500. In comparison DBV Technologies SA has a beta of 0.707, suggesting its less volatile than the S&P 500 by 29.271%.

Edap TMS SA has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. DBV Technologies SA offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Edap TMS SA pays -- of its earnings as a dividend. DBV Technologies SA pays out -- of its earnings as a dividend.

Edap TMS SA quarterly revenues are $14.4M, which are larger than DBV Technologies SA quarterly revenues of --. Edap TMS SA's net income of -$7M is higher than DBV Technologies SA's net income of -$30.4M. Notably, Edap TMS SA's price-to-earnings ratio is -- while DBV Technologies SA's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Edap TMS SA is 1.24x versus -- for DBV Technologies SA. Usually stocks with elevated PS ratios are considered overvalued.

Genfit SA has a net margin of -48.85% compared to Edap TMS SA's net margin of --. Edap TMS SA's return on equity of -42.5% beat Genfit SA's return on equity of --.

Edap TMS SA has a consensus price target of $10.67, signalling upside risk potential of 365.79%. On the other hand Genfit SA has an analysts' consensus of $10.17 which suggests that it could grow by 189.3%. Given that Edap TMS SA has higher upside potential than Genfit SA, analysts believe Edap TMS SA is more attractive than Genfit SA.

Edap TMS SA has a beta of 0.372, which suggesting that the stock is 62.782% less volatile than S&P 500. In comparison Genfit SA has a beta of 1.135, suggesting its more volatile than the S&P 500 by 13.542%.

Edap TMS SA has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Genfit SA offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Edap TMS SA pays -- of its earnings as a dividend. Genfit SA pays out -- of its earnings as a dividend.

Edap TMS SA quarterly revenues are $14.4M, which are larger than Genfit SA quarterly revenues of --. Edap TMS SA's net income of -$7M is higher than Genfit SA's net income of --. Notably, Edap TMS SA's price-to-earnings ratio is -- while Genfit SA's PE ratio is 32.57x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Edap TMS SA is 1.24x versus 2.64x for Genfit SA. Usually stocks with elevated PS ratios are considered overvalued.